(1 - 35 von 81
)
FDA announces first US gene therapy approval for cancer treatment -...
edition.cnn.com
... standard of care for this patient population," said Dr. Stephan Grupp, director of cancer immunotherapy at Children's Hospital of Philadelphia, ...
Cancer drug a major breakthrough — but it has a hefty price tag
nypost.com
... become the new standard of care for this patient population,” Dr. Stephan Grupp of Children's Hospital of Philadelphia said in a statement.
New data on risk vs benefit for potent CAR-T cancer drugs | Reuters
www.reuters.com
... results show "what it looks like when you roll this out to a bunch of different centers across the world," said Dr Stephan Grupp, ...
Cellectis: An Expert Review on Allogeneic CAR-T for Cancer ...www.finanznachrichten.de › nachrichten
www.finanznachrichten.de
Stephan Grupp, Chief of Cell Therapy and Transplant Section at the ... Follow Cellectis on social media: @Cellectis, LinkedIn and YouTube.
sortiert nach Relevanz / Datum